CLINICAL MANIFESTATION OF SYSTEMIC SCLEROSIS

Slides:



Advertisements
Similar presentations
SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
Advertisements

Scleroderma Nicole Bundy, MD, MPH Assistant Professor Division of Rheumatology and Immunology
(SLE).  Definition  Epidemiology  Pathophysiology  Clinical features  Classification and diagnosis  Treatment  Prognosis  Lupus related syndromes.
. The American Autoimmune Related Diseases Association (AARDA) is dedicated to the eradication of autoimmune diseases and the alleviation of the suffering.
XXXXXXXXXX Biology 1406 Class XXXXXX Fall 2010 Dr. Andrei Nesterovitch
Virginia Steen, MD Professor of Medicine
CREST J. Ryan Altman, MD AM REPORT 9 December 2009.
Autoantibodies in PM and DM Autoantibodies:>90% Autoantibodies:>90% Positive ANA:60-80% Positive ANA:60-80%  More in overlap  Low in IBM Defined antibodies:50%
Autoimmune Diseases Dr. Raid Jastania. Autoimmune Diseases Group of diseases with common pathological process Presence of auto-antibody ?defect in B-cells.
Scleroderma derived from greek and means hard skin
Systemic Sclerosis SCLERODERMA ד"ר גבריאל ש ברויאר היחידה לראומטולוגיה המרכז הרפואי שערי צדק.
1 Sponsored by: National Institutes of Health (NIH) through its Division of Allergy, Immunology and Transplantation (DAIT) in the National Institute of.
Dr Shoaib Raza.   Immune reactions against self antigens  Affects 1% to 2% of US population  Requirements for an autoimmune disorder:  Presence of.
Classification Criteria for Systemic Sclerosis An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative van.
Interventions for Clients with Connective Tissue Disease and Other Types of Arthritis.
Paediatric Rheumatology Phil Riley Consultant Paediatric Rheumatologist Teaching.
INFLAMMATORY MYOPTHIES
Connective tissue diseases
SCLERODERMA DEFINATION :-
Scleroderma (Systemic Sclerosis)
"On-line Atlas" of Dermatology and Rheumatology Cutaneous Manifestations of Rheumatic Diseases
Seronegative Spondyloarthropathies and Systemic Sclerosis Victor Politi, M.D., FACP Medical Director, SVCMC, School of Allied Health, Physician Assistant.
Interstitial Lung Disease MODULE G4 Chapter 28: pp
Good Morning ! October 3 rd,  An overlap syndrome associated with anti-U1-RNP (ribonucleic protein) antibodies with features of SLE, scleroderma,
-GOUT -Pseudogout Systemic sclerosis. A disease of Kings.
Classification of sclerodermas Localized sclerodermas Morhpea Linear scleroderma.
Interventions for Clients with Connective Tissue Disease and Other Types of Arthritis.
September 24,  20% diagnosed in childhood  Mostly in adolescence  F:M ratio  Prior to puberty - 3:1  After puberty - 9:1  Native Americans.
Elsevier items and derived items © 2006 by Elsevier Inc. Interventions for Clients with Connective Tissue Disease and Other Types of Arthritis.
Mixed Connective Tissue Disease
Systemic Sclerosis (Scleroderma)
SCLERODERMA Gentleman’s Review Daniel Martingano OMSII.
Connective Tissue Disorders Immune Disorders PT 635 Spring 2013 Lonnemann.
Systemic Sclerosis ANAS MUHANNAa MD,FACR AL-QUDS UNIVERSITY
Cardiac Pathology 3: Valvular Heart Disease, Cardiomyopathies and Other Stuff Kristine Krafts, M.D.
Diffuse connective tissue diseases. Modern pictures are of clinic, diagnostics. Доц. Н.З.Ярема.
Connective tissue diseases
Autoantibodies associated with Rheumatic disease
Lupus!! (Yay!!!…..???). Goals Outline The Basics Emergency Stuff –Presenting symptoms –Complications –Infection Quizzes… with prizes!
Systemic Lupus Erythematosus Angelique Davis Q: Why does seal have scars on his face? A: Discoid Lupus.
Scleroderma Lab Data and Diagnosis Iraj Salehi-Abari MD., Internist
Scleroderma & Pregnancy
How Charitable Organisations Support Research Presentation By: Sue Farrington Monday 10th October 2016.
Dr. Ashwin Kulkarni M.S.Ramaiah Medicial College Bangalore India
Systemic Sclerosis (Scleroderma)
Systemic sclerosis.
Scleroderma.
Scleroderma (Systemic Sclerosis)
Fig 1: Skin thickening and sclerodactyly Fig 2: Digital tip ulcers
Laser treatment of medical skin disease in women
Sjogren’s syndrome.
Objectives 1- Describe the clinical features and investigations of discoid lupus, subacute lupus , Systemic lupus erythematosus, systemic sclerosis, morphea.
Systemic Sclerosis (Scleroderma)
Musculoskeletal disorders
“Mixed Connective Tissue Disease: Still Crazy After All These Years”
Systemic Lupus Erythematosis
Systemic Sclerosis Criteria.
Gastrointestinal features
Research Project: The outcome of African American patients with scleroderma in relationship to autoantibody, genetics and socioeconomic status Donna Swistowski,
Scleroderma Fibrosis and vascular changes Uncommon
Scleroderma Description: Scleroderma (Sclero= hardening, Derma=skin) is a chronic autoimmune disorder characterized by the hardening of the skin, shrinking.
Autoimmune diseases Ali Al Khader, M.D. Faculty of Medicine
Systemic Sclerosis (Scleroderma) AND MIXED CONNECTIVE TISSUE DISORDES ( MCTD ) By Dr. Zahoor.
Diseases of skeletal muscle
Systemic sclerosis (SSc; also known as scleroderma) is a complex connective tissue disease (CTD) of unknown etiology. It is characterized by fibrotic.
Salman Waheeduddin MD Rheumatology, Aurora Health Care.
Chronic Glomerulonephritis
Presentation transcript:

CLINICAL MANIFESTATION OF SYSTEMIC SCLEROSIS Ahad Azami M.D. Rheumatologist

Clinical Features of SLE OUTLINE: Definition Epidemiology Clinical Features of SLE

Systemic Sclerosis (scleroderma) Systemic sclerosis is a chronic multisystem disorder of unknown etiology characterized by the overproduction and accumulation of collagen with thickening of the skin and by structural and functional abnormalities of visceral organs, including the GI tract, lung, heart and kidneys

CLASSIFICATION A.SYSTEMIC SCLEROSIS 1.Diffuse cutaneous scleroderma 2.limited cutanous scleroderma (CREST syndrome) 3.Sestemic sclerosis sine scleroderma B.LOCALIZED SCLERODERMA 1.Linear 2.Morphea

EPIDEMIOLOGY PREVALENCE:19-75 / 100000 FEMALE / MALE:3 / 1 AGE:30-50

CLINICAL MANIFESTATION

Systemic Sclerosis Diffuse Limited Skin Involvement Distal and proximal extremities, face, trunk Distal to elbows, face Raynaud’s Phenomenon Onset within one year or at time of skin changes May precede skin disease by years Organ Involvement Pulmonary (interstitial fibrosis); renal (renal crisis); gastrointestinal; cardiac GI, pulmonary hypertension Nail Fold Capillaries Dilation and dropout Dilation without significant dropout Antinuclear Antibodies Anti-topoisomerase Anti-centromere

Clinical Features of Systemic Sclerosis (% Patients during course of disease) Limited Diffuse Raynaud’s 95-100 90-95 Skin thickening 98 100 Subcutaneous calcinosis 50 10 Telangiectasia 85 40 Arthralgias/arthritis 70 Myopathy 5 Esophageal dysmotility 80 Pulmonary fibrosis 35 Pulmonary HTN 1 CHF 30 Renal crisis 15

RAYNOUD’S PHENOMENON

SKIN CHANGES 1.Edematous phase 2.Indurative phase(Sclerotic phase) 3.Atrophic phase

EDEMATOUS PHASE

INDURATIVE PHASE

SCLEROTIC PHASE

CALCIFICATION

PITTING SCAR

CAPILAROSCOPY

CREST SYNDROME

MORPHEA

LINEAR SCLERODERMA

MUSCULOSKELETAL MANIFESTATIONS Arthralgia Arthritis Myalgia Myositis Muscle atrophy

ACRO-OSTEOLYSIS

GI INVOLVEMENT ESOPHAGUS

GI INVOLVEMENT STOMACH & DEODENUM

GI INVOLVEMENT COLON

PULMONARY MANIFESTATIONS Alveolitis Interstitial fibrosis Pulmonary hypertension Aspiration pneumonia Pulmonary hemorrhage Pneumothorax Lung cancer

SCLERODERMA RENAL CRISIS Hypertension Uremia Proteinuria Hematuria

CARDIAC MANIFESTATIONS MYOCARDITIS PERICARDITIS CONDUCTION DEFECT CORONARY ARTERY DISEASE